Skip to main content

Table 2 Drug interaction probability scale

From: Reduced blood glucose levels by the combination of vadadustat in an elderly patient with chronic kidney disease who was receiving mitiglinide and sitagliptin: a case report

Question

Patient 1

1 Are there previous credible reports of this interaction in humans?

NA (0)

2 Is the observed interaction consistent with the known interactive properties of precipitant drug?

Y (+ 1)

3 Is the observed interaction consistent with the known interactive properties of object drug?

Y (+ 1)

4 Is the event consistent with the known or reasonable time course of the interaction (onset and/or offset)?

Y (+ 1)

5 Did the interaction remit upon dechallenge of the precipitant drug with no change in the object drug?

Y (+ 1)

6 Did the interaction reappear when the precipitant drug was readministered in the presence of continued use of object drug?

NA (0)

7 Are there reasonable alternative causes for the event?

N (0)

8 Was the object drug detected in the blood or other fluids in concentrations consistent with the proposed interaction?

NA (0)

9 Was the drug interaction confirmed by any objective evidence consistent with the effects on the object drug?

Y (+ 1)

10 Was the Interaction greater when the precipitant drug dose was increased or less when the precipitant drug dose was decreased?

NA (0)

Total scores (Causality of drug-drug interaction)

5 (Probable)

  1. Abbreviations: Y Yes, N No, NA not applicable
  2. The aforementioned scoring procedure was proposed by Horn et al. [3]
  3. The object drug is sitagliptin, and the precipitant drug is vadadustat
  4. The answers and scores for each question were described. Drug interaction probability score categories are classified into four groups: doubtful (0–1), possible (2–4), probable (5–8), and highly probable (9–11)